Skip to main content
. 2012 Mar;97(3):410–415. doi: 10.3324/haematol.2011.053199

Figure 2.

Figure 2

Baseline plasma TARC levels in relation to tumor burden. (A) In newly diagnosed patients, plasma TARC levels in stage II–IV disease were significantly higher compared to stage I disease (P≤0.01). (B) Patients with bulky disease had significantly higher baseline plasma TARC levels compared to patients without bulky disease (P<0.01). (C) Baseline plasma TARC levels significantly correlated with the pre-treatment metabolic volume as determined by quantification of the FDG-PET results.